Publication | Closed Access

Hypofractionated Radiotherapy followed by Hypofractionated Boost with weekly concurrent chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Results of A Prospective Phase II Study (GASTO-1049)

Radiation MedicineRadiation TherapyMedicineWeekly Concurrent ChemotherapyHypofractionated BoostCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences